HIV-related lymphoma. Issue 6 (November 2010)

• Record Type: Journal Article
• Authors: Lee, Belinda; Bower, Mark; Newsom-Davis, Thomas; Nelson, Mark
• Is Part Of: HIV therapy. Volume 4:Issue 6(2010)
• Page Start: 649
• Page End: 659
• Publication Date: 2010-11
• Subjects: Burkitt's lymphoma -- diffuse large B-cell lymphoma -- HIV-related lymphoma -- Hodgkin's lymphoma -- non-Hodgkin's lymphoma; HIV (Viruses) -- Treatment -- Periodicals; HIV (Viruses) -- Research -- Periodicals; 616.979206
• DOI: 10.2217/hiv.10.54
• Languages: English
• ISSNs: 1758-4310

Abstract

Since the introduction of highly active antiretroviral therapy, the natural history of HIV infection has changed dramatically, and with it the epidemiology of HIV-related lymphoma. HIV-related lymphomas have increased as a percentage of first AIDS-defining illness. The most prevalent of the HIV-related lymphomas is diffuse large B-cell non-Hodgkin's lymphoma, followed by Burkitt's lymphoma. Although not considered an AIDS-defining illness, Hodgkin's lymphoma is increasing in incidence in those with HIV infection. Treatment outcome and prognosis has improved significantly over the last decade. Paradigms of therapy have shifted, with approaches aimed at complete remission rather than palliation. This review discusses the biology and changes in epidemiology of HIV-related lymphoma and also reviews other key developments in the management of this disease.